Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
about
Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients.PD-1/PD-L1 antibodies efficacy and safety versus docetaxel monotherapy in advanced NSCLC patients after first-line treatment option: systems assessment.Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors.Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer.Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer.PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study.Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer.Adverse prognostic value of PD-L1 expression in primary resected pulmonary squamous cell carcinomas and paired mediastinal lymph node metastases.PD-L1 immunohistochemistry for non-small cell lung carcinoma: which strategy should be adopted?YAP regulates PD-L1 expression in human NSCLC cells.Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP).The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent
P2860
Q41201725-B095E2B2-822E-4D46-9B20-44F36BFE7205Q41708775-8409E844-813B-490A-BF24-2865C7230907Q42700740-37D5E2B5-3DAA-4240-9E10-2425B122D57DQ46037895-B4AC9B5F-FFED-4C08-98B6-01F0777D7385Q46642782-E9B836BE-EBFF-4059-A878-A62AE7A760FBQ47103927-336671DC-9E24-4413-8975-B00CD28C28B3Q47763725-3E4808FF-07BC-4136-A18D-0779A2102653Q48105843-276A12AB-C542-4C46-BA74-65238E6A8BF2Q48620065-B40CBA74-0E64-43B7-88CF-4404D929F9E6Q49569691-E0A81262-A7DF-4CD7-A74D-269C89AB2AC8Q53217202-BC59FFB2-3549-4F33-90F4-4B8A6F050516Q57816676-CB8F33F1-B605-45AA-B543-3FA1E998F58C
P2860
Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Programmed cell death ligand-1 ...... in non-small cell lung cancer?
@en
Programmed cell death ligand-1
@nl
type
label
Programmed cell death ligand-1 ...... in non-small cell lung cancer?
@en
Programmed cell death ligand-1
@nl
prefLabel
Programmed cell death ligand-1 ...... in non-small cell lung cancer?
@en
Programmed cell death ligand-1
@nl
P2860
P1476
Programmed cell death ligand-1 ...... in non-small cell lung cancer?
@en
P2860
P304
P356
10.20892/J.ISSN.2095-3941.2016.0009
P577
2016-06-01T00:00:00Z